Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
Sponsor: InventisBio Co., Ltd
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of D-2570 in the treatment of active systemic lupus erythematosus.
Official title: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of D-2570 in Patients With Active Systemic Lupus Erythematosus
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-01-15
Completion Date
2028-12-31
Last Updated
2026-01-07
Healthy Volunteers
No
Conditions
Interventions
D-2570
Participants will be assigned to one of the following groups: Group A, Group B, Group C, or the placebo control group.
D-2570 Placebo
D-2570 Placebo